Skip to content

Characterization of Suicidal Depression

Characterization of Suicidal Depression Within a Large Cohort of Inpatients: a One-year Prospective Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05046587
Enrollment
898
Registered
2021-09-16
Start date
2021-06-01
Completion date
2021-09-30
Last updated
2021-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Suicide, Suicidal Ideation, Suicidal Depression

Brief summary

Antidepressants are widely used to prevent suicidal risk. However, even though the use of antidepressants has been associated with a 40-60% decrease in suicidal risk, they do not seem to be sufficient and appropriate. Indeed recent studies have shown that patients with a history of suicide attempt and/or with current suicidal ideation (SI) respond less well to antidepressant treatments. This suggests that patients with depression with SI may be different from those with depression without SI, thus requiring specific treatments for both SI reduction and depressive remission. In other words, suicidal depression may be a specific subtype of depression. The study aims to characterize the clinical phenotype of patients with suicidal depression vs. those without suicidal depression, and to assess the occurrence of suicidal events at one year in patients with suicidal depression vs. without suicidal depression. All data having already been collected during the particpation of patients in various clinical research studies of the department

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years old * Hospitalization in the Department of Emergency Psychiatry and Acute Care (Montpellier University Hospital) between 2012 and 2019 * Having being enrolled in one the department's clinical studies between 2012 and 2019 * Moderate to severe characterized depressive episode according to DSM-5 diagnostic criteria (severity assessed with BDI, IDSC-30 and QIDS)

Exclusion criteria

* Protection by law (guardianship or curatorship) * Deprivation of liberty (by judicial or administrative decision) * Bipolar disorder

Design outcomes

Primary

MeasureTime frameDescription
characterization of the patient clinical phenotypeday 1characterization of the patient clinical phenotype

Secondary

MeasureTime frameDescription
Suicidal events at one year1 yearOccurrence of suicidal events (actual, interrupted and aborted or self-aborted suicide attempts) assessed with C-SSRS suicidal behaviour subscale (4 yes/no questions)
Hospitalization for suicidal ideation1 yearOccurrence of hospitalization for suicidal ideation, based on the patient medical record

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026